#$%^&*AU2011265315A120120119.pdf#####Abstract The invention includes methods of neuroprotection, inducing release of neurotrophic factors, inhibiting the over5 activation of innate immune cells, attenuating the toxininduced death and/or damage of tissues, reducing inflammation, treating an inflammation-related condition, and inhibiting NADPH oxidase, that includes contacting or administering an effective amount of at least one compound of the invention 10 that include: valproic acid, sodium butyrate, and salts thereof opioid peptides a peptide comprising the tripeptide GGF and morphinans, such as naloxone, naltrexone, 3-hydroxymorphinan and dextromethorphan. 25065351 (GHMatters) P62818.AU 19-Dec-11
